Project Details
Description
A Phase 1b\2,Double-Blind, Placebo-Controlled, Randomized, Parallel-Arm Study to Explore the Safety, Pharmacokinetics, and Proof of Biological Activity of DS-7011a in Patients with Systemic Lupus Erythematous and Active Cutaneous Lupus Erythematosus
| Status | Active |
|---|---|
| Effective start/end date | 5/25/23 → 5/31/26 |
Funding
- DAIICHI SANKYO, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.